What is lymphatic filariasis?
Lymphatic filariasis (LF) is a mosquito-transmitted disease caused by parasitic worms that damage the human-lymph system.
It can cause severe and extensive swelling of the lower limbs (lymphedema), which can be accompanied by painful episodes of fever. People with lymphedema are prone to bacterial infections that can lead to a mobility-limiting condition where the skin thickens and hardens (elephantiasis). In men, lymphatic filariasis can also result in the swelling of the scrotum (hydrocele).
Lymphatic filariasis affects the poorest communities, preventing individuals from living a productive working and social life, further trapping them in the cycle of poverty.
People affected by lymphatic filariasis67 million people are infected by lymphatic filariasis 36 million people are living with hydrocele and lymphedema
WHO NTD roadmap targets for lymphatic filariasis
The World Health Organization’s roadmap on NTDs set out a comprehensive plan for the control, elimination and eradication of various neglected tropical diseases by 2020, including lymphatic filariasis.
Lymphatic filariasis target: Global elimination as a public health problem by 2020
Progress and scorecard from the 5th progress report
Countries that have eliminated lymphatic filariasis
9 countries have eliminated lymphatic filariasis since 2012:
- Maldives (2016)
- Sri Lanka (2016)
- Cambodia (2016)
- Cook Islands (2016)
- Niue (2016)
- Vanuatu (2016)
- Marshall Islands (2017)
- Togo (2017)
- Tonga (2017)
Mass drug administration progress for lymphatic filariasis
People receiving preventive chemotherapy for lymphatic filariasis
Since the London Declaration was signed in 2012 and partners committed to defeating neglected tropical diseases, the number of people receiving preventive chemotherapy for lymphatic filariasis has increased considerably.
- Data is provided by the World Health Organization
- Photo: © GSK / Marcus Perkins